Keros Therapeutics
KROS
#7006
Rank
โ‚ฌ0.36 B
Marketcap
9,07ย โ‚ฌ
Share price
-0.70%
Change (1 day)
-84.46%
Change (1 year)

EPS for Keros Therapeutics (KROS)

EPS in 2023 (TTM): -4,28ย โ‚ฌ

According to Keros Therapeutics's latest financial reports the company's current EPS (TTM) is -4,15ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -3,80ย โ‚ฌ a decrease over its 2021 EPS that were of -2,31ย โ‚ฌ.

EPS history for Keros Therapeutics from 2019 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-4,28ย โ‚ฌ12.61%
2022-3,80ย โ‚ฌ64.68%
2021-2,31ย โ‚ฌ4.65%
2020-2,20ย โ‚ฌ71.14%
2019-1,29ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,99ย โ‚ฌ-51.98%๐Ÿ‡บ๐Ÿ‡ธ USA